Ziopharm raises $50M in follow-on

Cancer company Ziopharm Oncology Inc. (NASDAQ:ZIOP) raised $50 million through the sale of 9.7 million shares at $5.15 in a follow-on underwritten by Guggenheim. The price is a 28% discount to Ziopharm's close of $7.12 on Thursday.

Ziopharm said it sold the shares to a single institutional investor. The company did not respond to inquiries...